Health insurance giant Aetna is funding a study of whether women who should be offered genetic screening tests for breast and ovarian cancer risk are indeed being offered the tests, reports the Wall Street Journal's Health Blog.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.